Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia

Urologia Internationalis

Volumn 94, Issue 2, 2015, Pages 181-186

  Bulut, Suleyman ^a   Ozden, Cuneyt ^a   Aktas, Binhan Kagan ^a   Deren, Tagmac ^a   Tagci, Suleyman ^a   Gokkaya, Cevdet Serkan ^a   Baykam, Mehmet Murat ^a   Memis, Ali ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

Author keywords

Alpha adrenergic blockers; Benign prostatic hyperplasia; Doppler ultrasonography; Transurethral prostate resections

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; QUINAZOLINE DERIVATIVE; URINARY TRACT AGENT;

ADULT; ARTICLE; BLADDER FUNCTION; BLADDER RESISTIVE INDEX; DOPPLER FLOWMETRY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATIC RESISTIVE INDEX; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE FLOW RATE; AGED; BLADDER; COMPARATIVE STUDY; COMPLICATION; CONVALESCENCE; DRUG EFFECTS; ECHOGRAPHY; LOWER URINARY TRACT SYMPTOMS; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROSTATECTOMY; PROSTATIC HYPERPLASIA; TIME; URODYNAMICS;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; QUINAZOLINES; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; URINARY BLADDER; URODYNAMICS; UROLOGICAL AGENTS;

EID: 84924164134     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000363581     Document Type: Article

References (31)

1. Park HJ, Won JE, Sorsaburu S, Rivera PD, Lee SW: Urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and LUTS/BPH with erectile dysfunction in Asian men: a systematic review focusing on tadalafil. World J Mens Health 2013; 31: 193-207
2. Robert G, Descazeaud A, Azzouzi R, et al: Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years. Urol Int 2010; 84: 424-429
3. Oelke M, Bachmann A, Descazeaud A, et al; European Association of Urology: EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013; 64: 118-140
4. Chen JS, Chang CH, Yang WH, Kao YH: Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study. BJU Int 2012; 110: 896-901
5. Konstantinidis C, Samarinas M, Andreadakis S, Xanthis S, Skriapas K: Lower urinary tract symptoms associated with benign prostatic hyperplasia: combined treatment with fesoterodine fumarate extended-release and tamsulosin-a prospective study. Urol Int 2013; 90: 156-160
6. Santos Dias J: Benign prostatic hyperplasia: clinical manifestations and evaluation. Tech Vasc Interv Radiol 2012; 15: 265-269
7. Oh MM, Kim JW, Kim JJ, Moon du G: Is there a correlation between the outcome of transurethral resection of prostate and preoperative degree of bladder outlet obstruction? Asian J Androl 2012; 14: 556-559
8. Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP: Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressureflow studies. J Urol 1998; 159: 191-194
9. Tsuru N, Kurita Y, Masuda H, Suzuki K, Fujita K: Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy. Int J Urol 2002; 9: 427-430
10. Kojima M, Watanabe H, Watanabe M, Okihara K, Naya Y, Ukimura O: Preliminary results of power Doppler imaging in benign prostatic hyperplasia. Ultrasound Med Biol 1997; 23: 1305-1309
11. Ozdemir H, Onur R, Bozgeyik Z, Orhan I, Ogras MS, Ogur E: Measuring resistance index in patients with BPH and lower urinary tract symptoms. J Clin Ultrasound 2005; 33: 176-180
12. Ozden C, Gunay I, Deren T, et al: Effect of transurethral resection of prostate on prostatic resistive index. Urol Int 2010; 84: 191-193
13. Zhang X, Li G, Wei X, et al: Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia. J Urol 2012; 188: 881-887
14. Pinggera GM, Mitterberger M, Steiner E, et al: Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography. BJU Int 2008; 102: 470-474
15. Pinggera GM, Mitterberger M, Pallwein L, et al: Alpha-blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU Int 2008; 101: 319-324
16. Amiel GE, Slawin KM: Newer modalities of ultrasound imaging and treatment of the prostate. Urol Clin North Am 2006; 33: 329-337
17. Murphy KJ, Rubin JM: Power Doppler: it's a good thing. Semin Ultrasound CT MR 1997; 18: 13-21
18. Shinbo H, Kurita Y, Nakanishi T, et al: Resistive index: a newly identified predictor of outcome of transurethral prostatectomy in patients with benign prostatic hyperplasia. Urology 2010; 75: 143-147
19. Fultz NH, Herzog AR: Epidemiology of urinary symptoms in the geriatric population. Urol Clin North Am 1996; 23: 1-10
20. Shenfeld OZ, Meir KS, Yutkin V, Gofrit ON, Landau EH, Pode D: Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age? Urology 2005; 65: 181-184
21. Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, Saenz de Tejada I: Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998; 160: 2216-2222
22. Murray SP, Stoney RJ: Chronic visceral ischemia. Cardiovasc Surg 1994; 2: 176-179
23. Koskimaki J, Hakama M, Huhtala H, Tammela TL: Association of smoking with lower urinary tract symptoms. J Urol 1998; 159: 1580-1582
24. Willder JM, Walker VC, Halbert GL, et al: Body mass index predicts failure of surgical management in benign prostatic hyperplasia. Urol Int 2013; 90: 150-155
25. Willder JM, Walker VC, Halbert GL, et al: The prognostic use of inflammation and tissue necrosis in benign prostatic hyperplasia. Urol Int 2013; 91: 19-25
26. Levin RM, Levin SS, Zhao Y, Buttyan R: Cellular and molecular aspects of bladder hypertrophy. Eur Urol 1997; 32: 15-21
27. Belenky A, Abarbanel Y, Cohen M, Yossepowitch O, Livne PM, Bachar GN: Detrusor resistive index evaluated by Doppler ultrasonography as a potential indicator of bladder outlet obstruction. Urology 2003; 62: 647-650
28. Goi Y, Tomiyama Y, Nomiya M, Sagawa K, Aikawa K, Yamaguchi O: Effects of silodosin, a selective 1A-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction. J Urol 2013; 190: 1116-1122
29. Kim JW, Jang HA, Bae JH, Lee JG: Effects of coenzyme Q10 on bladder dysfunction induced by chronic bladder ischemia in a rat model. J Urol 2013; 189: 2371-2376
30. Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE: Protective effect of a 3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia. Eur Urol 2013; 64: 664-671
31. Wada N, Watanabe M, Kita M, Matsumoto S, Kakizaki H: Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Neurourol Urodyn 2012; 31: 659-663.